BEXSERO
Google image searchProduct monograph
Active ingredients
recombinant neisseria meningitidis group b nhba fusion protein, 50 MCG/0.5 ML
recombinant neisseria meningitidis group b nada protein, 50 MCG/0.5 ML
recombinant neisseria meningitidis group b fhbp fusion protein, 50 MCG/0.5 ML
outer membrane vesicles (neisseria meningitidis group b nz98/254 strain), 25 MCG/0.5 ML
DIN: 02417030
Dosage form(s): SUSPENSION
Route(s) of administration: INTRAMUSCULAR
Description: MULTICOMPONENT MENINGOC. B VACCINE (R-DNA ADSORBED). 0.5ML PFS.
Schedule: Schedule D
Company: GLAXOSMITHKLINE INC
Date: 08-SEP-2016
ATC:
- J07 — VACCINES (ATC, ATC/DDD, )
- J07A — BACTERIAL VACCINES (ATC, ATC/DDD)
- J07AH — Meningococcal vaccines (ATC, ATC/DDD)
- J07AH09 — MENINGOCOCCUS B, MULTICOMPONENT VACCINE (ATC/DDD)
Reference brand drug: Bexsero
External Links for Bexsero
Search on Google
- Bexsero side effects
- Bexsero dosage
- recombinant neisseria meningitidis group b nhba fusion protein side effects
- recombinant neisseria meningitidis group b nhba fusion protein dosage
- recombinant neisseria meningitidis group b nada protein side effects
- recombinant neisseria meningitidis group b nada protein dosage
- recombinant neisseria meningitidis group b fhbp fusion protein side effects
- recombinant neisseria meningitidis group b fhbp fusion protein dosage
- outer membrane vesicles side effects
- outer membrane vesicles dosage
Glaxosmithkline Inc
Go to GlaxoSmithKline website to see drug product details. Sometimes you can find bexsero photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.
